The DST Knockout AGS Polyclonal Cells product provides a CRISPR/Cas9-edited polyclonal knockout cell population derived from the AGS human gastric adenocarcinoma cell line, featuring targeted disruption of the dystonin (DST) gene. This polyclonal model is designed to support loss-of-function studies of DST, a critical cytoskeletal linker protein, within a physiologically relevant epithelial context. The knockout population enables investigation of DST-dependent cellular processes without relying on single-cell cloning, offering a heterogeneous but gene-disrupted pool suitable for high-content screening, population-level functional assays, and mechanistic pathway analysis. Researchers can expect a versatile tool for probing DST biology in a cancer-relevant background, with applications spanning adhesion, migration, and mechanical stress responses.
The AGS host cell line originates from a gastric adenocarcinoma isolated from a female patient, and it has been extensively characterized as an in vitro model of gastric epithelium. AGS cells are widely employed in studies of Helicobacter pylori infection and gastric carcinogenesis, as they retain key features of gastric epithelial biology, including polarized morphology and adhesion protein expression. Their robust growth, well-documented signaling networks, and tractable genetic manipulation make AGS a preferred platform for cancer biology and drug discovery research. Using this host background, the DST knockout polyclonal population offers a contextually relevant system for dissecting the role of dystonin in gastric cancer progression, particularly in the setting of altered cell?Cmatrix interactions and epithelial integrity.
Dystonin, a member of the plakin family, functions as a cytolinker that mechanically integrates the actin cytoskeleton and intermediate filament network with hemidesmosomal adhesion complexes. Through direct interactions with keratin intermediate filaments, vimentin, actin, integrin ??6??4, collagen XVII, and plectin, DST stabilizes cell?Cmatrix junctions and confers resilience against mechanical stress. Dystonin expression is transcriptionally regulated by the p63 transcription factor and is activated downstream of integrin-mediated adhesion and mechanical cues. When DST function is lost, the linkage between cytoskeletal elements and laminin-332?Canchored adhesion sites is compromised, leading to reduced cell adhesion, disrupted intermediate filament organization, and increased susceptibility to mechanical strain. This mechanistic framework underscores the protein??s role in maintaining epithelial tissue integrity and highlights potential crosstalk with integrin signaling and stress-response pathways.
In the AGS gastric adenocarcinoma context, DST knockout provides a powerful model to explore how loss of cytoskeletal anchoring influences malignant phenotypes. Because gastric epithelial cells are continuously exposed to mechanical forces from peristalsis and luminal pressure, DST deficiency may promote detachment, anoikis resistance, and invasive behavior. Researchers can use this system to examine the contribution of dystonin to tumor cell adhesion, collective migration, and metastasis, as well as to evaluate its involvement in resistance to mechanical stress or chemotherapeutic agents. The model allows dissection of DST??s role in hemidesmosome dynamics and epithelial plasticity in a cancer cell background that naturally expresses relevant adhesion and signaling molecules.
This polyclonal knockout population is ideally suited for a broad range of experimental approaches, including western blotting and immunofluorescence to assess DST protein loss and subcellular distribution, cell adhesion and spreading assays on defined matrices, migration and invasion assays to evaluate metastatic potential, and mechanical stretch assays to interrogate stress responses. Co-immunoprecipitation can further identify alterations in DST-containing protein complexes. Applications include investigating gastric cancer invasion mechanisms, studying cytoskeletal crosstalk in drug resistance, and screening for modulators of hemidesmosome stability. For additional information or technical support, please contact Ascent Research.
